Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1761-1770 of 2933 for cancer

Edit search filters
  1. Safety Study Of Enoblituzumab (MGA271) In Combination With Pembrolizumab In Refractory Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Anastrozole And Letrozole After Surgery For The Treatment Of Stage I-III Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. VX15/2503 In Combination With Avelumab In Advanced Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Anetumab Ravtansine And Atezolizumab In Treating Participants With Advanced Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Taselisib And Enzalutamide In Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

    Rochester, MN

  6. Intravesical Administration Of INSTILADRIN (RAd-IFN With Syn3) In Patients With Bladder Cancer

    Rochester, MN

  7. Nivolumab With Or Without Ipilimumab In Treating Patients With Refractory Metastatic Anal Canal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Post Operative Adjuvant Therapy De-intensification Trial For Human Papillomavirus-related, P16+ Oropharynx Cancer

    Scottsdale/Phoenix, AZ

  9. Staging Prostate Cancer With Hybrid C11-Choline PET/MR And MpMRI

    Scottsdale/Phoenix, AZ

  10. ASCENT-Study Of Sacituzumab Govitecan In Refractory/Relapsed Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer